Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
Randomized Study With New Combination Chemotherapies in Advanced Non-Small Cell Lung Cancer
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
A PHASE3 clinical study on Lung Cancer, this trial is completed. The trial is conducted by European Organisation for Research and Treatment of Cancer - EORTC and has accumulated 6 data snapshots since 1998. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Aug 1998
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- European Organisation for Research and Treatment of Cancer - EORTC
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
's-Gravenhage (Den Haag, the Hague), Netherlands, 's-Hertogenbosch, Netherlands, Amsterdam, Netherlands, Antwerp, Belgium, Apeldoorn, Netherlands, Arnhem, Netherlands, Athens, Greece, Bellinzona, Switzerland, Biella, Italy, Breda, Netherlands and 20 more location s